Stock Earnings

Question 1

Rallybio Corp 的關鍵財務報表是什麼？

Accepted Answer

根據最新的財務報表（Form-10K），Rallybio Corp 的總資產為 $68，淨loss為 $-57

Question 2

RLYB 的關鍵財務比率是什麼？

Accepted Answer

Rallybio Corp 的流動比率為 11.33，淨利潤率為 0，每股銷售為 $0。

Question 3

Rallybio Corp 的收入按細分市場或地理位置如何劃分？

Accepted Answer

Rallybio Corp largest revenue segment is Life-transforming Therapies, at a revenue of 636,000 in the most earnings release.For geography, United States is the primary market for Rallybio Corp, at a revenue of 636,000.

Question 4

Rallybio Corp 是否盈利？

Accepted Answer

no，根據最新的財務報表，Rallybio Corp 的淨loss為 $-57

Question 5

Rallybio Corp 有負債嗎？

Accepted Answer

yes，Rallybio Corp 的負債為 6

Question 6

Rallybio Corp 的流通股有多少？

Accepted Answer

Rallybio Corp 的總流通股為 41.51

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	15	19	25	27	18	7
Research & Development	23	41	53	40	26	17
Operating Expenses	38	61	78	67	45	25
Other Non Operating Income (Expenses)	22	0	0	0	0	0
Pretax Income	-14	-57	-74	-66	-47	-26
Income Tax Expense	--	--	--	--	0	0
Net Income	-14	-57	-74	-66	-47	-26
Net Income Growth	-79%	-23%	12%	40%	81%	53%
Shares Outstanding (Diluted)	45.05	43.54	40.44	31.82	25.52	2.66
Shares Change (YoY)	0%	8%	27%	25%	859%	55%
EPS (Diluted)	-0.32	-1.32	-1.84	-2.09	-1.84	-9.95
EPS Growth	-78%	-28%	-12%	14%	-82%	-2%
Free Cash Flow	-35	-49	-60	-57	-45	-22
Free Cash Flow Per Share	-0.77	-1.12	-1.48	-1.79	-1.76	-8.27
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-38	-60	-78	-67	-45	-25
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-38	-60	-78	-67	-45	-25
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	0%	0%

Rallybio Corp (RLYB) Price

RLYB Stock Price Chart

RLYB Income

Follow-Up Questions